Cognizant Surges to Target After Missing Last Quarter
Cognizant Technology Solutions Corporation stock rallied 25% to $70.54, surpassing the $67.10 analyst consensus target ahead of October 29 earnings. The company's Q2 miss and insider sales at lower pr
Cognizant Surges 25% Past Analyst Target Before Earnings
NEW YORK, October 24 —
Cognizant Technology Solutions Corporation (CTSH) is trading at $70.54, above its analyst consensus price target, after a 25% nine-session rally that the company's most recent earnings report does nothing to justify. The last time CTSH reported, it missed EPS estimates for the first time in four quarters. The next test arrives October 29.
- Q3 2026 consensus EPS: $1.46, up 5% from $1.39 a year ago; report due October 29 before market open.
- Shares at $70.54 exceed the $67.10 analyst consensus target; $33.4B market cap, 11.1x forward P/E.
- All three open-market insider sales in the 90-day window priced between $56.88 and $63.37, below the current share price.
The Rally That Outran the Results
Cognizant is an IT services and consulting giant serving banks, insurers, healthcare providers, and manufacturers across North America and Europe with AI-driven services, consulting, and application development. The stock rallied 25% over nine consecutive sessions on two catalysts: a DyFlex acquisition that Wedbush analysts said should expand the company's footprint beyond core markets, and an October 6 SEC filing disclosing a material definitive agreement and a new direct financial obligation. Neither document quantified financial terms publicly. The most recent earnings data point, Q2 2026 EPS of $1.37 against a $1.38 consensus per the Q2 earnings filing, is a -0.7% miss that snapped three consecutive beats.
Insiders Sold the Rally
Insiders were selling while the market was buying. CLO and CAO John Sunshin Kim made the largest discretionary open-market sale in the 90-day window, offloading 2,500 shares at $63.37 per filings, while CEO Ravi Kumar Singisetti disposed of 8,187 shares at $64.58 through a tax-withholding transaction the day he exercised options on 15,092 shares. Net open-market insider purchases over the 90-day window: zero. Tax-withholding sales are mechanical, not discretionary. But Kim's open-market sale was a choice, at $63.37, roughly 10% below current levels.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| CTSH | $33.4B | 11.1x | +3.9% |
| INFY | $50.0B | 14.6x | -29.3% |
| WIT | $20.9B | 14.1x | -21.6% |
| ADSK | $52.7B | 17.8x | -19.4% |
| FISV | $26.5B | 6.3x | -60.2% |
| FAST | $59.6B | 36.8x | +21.1% |
October 29 Is the Verdict
Analysts project Q3 2026 EPS of $1.46, a 5% increase from $1.39 a year ago. At 11.1x forward earnings with $2.22 billion in trailing free cash flow and 4.5% revenue growth, the DCF math is not obviously hostile. The problem is sequencing: CTSH has crossed its $67.10 analyst target on momentum alone, before the earnings delivery that would justify it. A Q3 print below $1.40 strips the rally of any fundamental defense; anything above $1.50 reframes DyFlex as a genuine growth catalyst rather than narrative packaging. Run the free Cognizant Technology Solutions Corporation deep-dive → to track the October 29 print.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
Frequently Asked Questions
When is Cognizant's next earnings report?
Cognizant's Q3 2026 earnings report is due October 29 before market open. The consensus EPS estimate is $1.46, up 5% from $1.39 a year ago.
What is Cognizant's current stock price?
Cognizant is trading at $70.54, which exceeds the analyst consensus price target of $67.10. The company has a $33.4B market cap and trades at 11.1x forward P/E.
Why did Cognizant stock rally 25%?
The company rallied over nine sessions following a DyFlex acquisition that Wedbush analysts said should expand the company's footprint beyond core markets, and an October 6 SEC filing disclosing a material definitive agreement. However, the most recent earnings data, Q2 EPS of $1.37 against a $1.38 consensus, was a miss that snapped three consecutive beats.
Are Cognizant insiders buying or selling?
Insiders were selling the rally rather than buying. CLO John Sunshin Kim made an open-market sale of 2,500 shares at $63.37, while CEO Ravi Kumar Singisetti disposed of 8,187 shares at $64.58 through a tax-withholding transaction. Net open-market insider purchases over the 90-day window: zero.
Is Cognizant's valuation justified?
At 11.1x forward earnings with $2.22 billion in trailing free cash flow and 4.5% revenue growth, the DCF math is not obviously hostile. However, CTSH has crossed its $67.10 analyst target on momentum alone before the earnings delivery that would justify it.
CTSH shares have gained approximately 25% over nine consecutive sessions to $70.54, breaching the $67.10 analyst consensus price target just five days before Q3 2026 earnings — arriving after the company's most recent quarter snapped a three-beat streak with a narrow miss.